Pfizer Inc. (PFE)
29.39
-0.49
(-1.64%)
USD |
NYSE |
Nov 06, 16:00
29.35
-0.04
(-0.14%)
After-Hours: 20:00
Pfizer Market Cap : 167.52B for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 167.52B |
| November 05, 2026 | 170.32B |
| November 04, 2026 | 175.50B |
| November 03, 2026 | 171.00B |
| November 02, 2026 | 174.82B |
| October 30, 2026 | 173.96B |
| October 29, 2026 | 170.69B |
| October 28, 2026 | 167.84B |
| October 27, 2026 | 169.83B |
| October 26, 2026 | 169.77B |
| October 23, 2026 | 171.14B |
| October 22, 2026 | 173.36B |
| October 21, 2026 | 170.12B |
| October 20, 2026 | 171.60B |
| October 19, 2026 | 167.78B |
| October 16, 2026 | 168.58B |
| October 15, 2026 | 167.78B |
| October 14, 2026 | 166.47B |
| October 13, 2026 | 161.68B |
| October 12, 2026 | 161.85B |
| October 09, 2026 | 161.17B |
| October 08, 2026 | 158.55B |
| October 07, 2026 | 159.57B |
| October 06, 2026 | 156.72B |
| October 05, 2026 | 156.21B |
| Date | Value |
|---|---|
| October 02, 2026 | 158.43B |
| October 01, 2026 | 160.26B |
| September 30, 2026 | 162.54B |
| September 29, 2026 | 163.68B |
| September 28, 2026 | 163.68B |
| September 25, 2026 | 163.39B |
| September 24, 2026 | 161.91B |
| September 23, 2026 | 160.60B |
| September 22, 2026 | 159.17B |
| September 21, 2026 | 158.09B |
| September 18, 2026 | 157.63B |
| September 17, 2026 | 157.52B |
| September 16, 2026 | 156.49B |
| September 15, 2026 | 157.01B |
| September 14, 2026 | 157.98B |
| September 11, 2026 | 157.98B |
| September 10, 2026 | 157.58B |
| September 09, 2026 | 158.32B |
| September 08, 2026 | 158.38B |
| September 04, 2026 | 162.14B |
| September 03, 2026 | 164.19B |
| September 02, 2026 | 165.38B |
| September 01, 2026 | 162.71B |
| August 31, 2026 | 162.19B |
| August 28, 2026 | 159.34B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 664.89B |
| Eli Lilly & Co. | 1.274T |
| Merck & Co., Inc. | 361.95B |
| Bristol Myers Squibb Co. | 127.01B |
| Abbott Laboratories | 190.39B |
Market Cap Related Metrics
| PE Ratio | 42.03 |
| PS Ratio | 2.641 |
| Price to Book Value | 1.882 |
| Price to Free Cash Flow | 14.25 |
| Price | 29.39 |
| Earnings Yield | 2.38% |
| Operating PE Ratio | 10.17 |
| Normalized PE Ratio | 12.95 |